📑Prosfora gia tin promitheia Emvolion ar.diag.F.Y.Y. 139/2022 (YY)
Procurement process summary
This process is to purchase Prosfora gia tin promitheia Emvolion ar.diag.F.Y.Y. 139/2022 (YY).
This contract was awarded by 🇨🇾 Υπουργείο Υγείας for an amount of EUR 970,650 to 1 supplier. It was published on 2022-10-24 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇨🇾 Υπουργείο Υγείας Buying unitnot reported Publication date2022-10-24 Contest statusnot reported DescriptionPromitheia EmvolionAwards
This award was granted to GEO. PAVLIDES ARAOUZOS PHARMACEUTICALS LTD by Υπουργείο Υγείας for an amount of EUR 970,650. The procurement process was conducted through open for the category of goods. The award was granted on 2023-01-16. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇨🇾 GEO. PAVLIDES ARAOUZOS PHARMACEUTICALS LTD | EUR 970,650 | 2023-01-16 | 1 |
Market context and opportunities
The execution of this contract allows the entity Υπουργείο Υγείας to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberCY_ocds-70d2nz-aacf1d4e-255c-45eb-88d7-6faaca33480e-award-1Publication date2022-10-24Contract datenot reportedAward date2023-01-16CategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
